Danaher Q1 Revenues Increase 11 Percent | GenomeWeb

The story has been updated to include comments from Danaher's CEO.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher today reported an 11 percent rise in first-quarter sales with its Life Sciences and Diagnostics segment jumping 22 percent.

For the three months ended April 1, the Washington-based conglomerate said that total sales came in at $3.35 billion, compared to $3.01 billion the year before. Wall Street had a consensus estimate of $3.32 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.